Corrections

Short cuts

BMJ 2006; 332 doi: https://doi.org/10.1136/bmj.332.7550.1138-b (Published 11 May 2006) Cite this as: BMJ 2006;332:1138

More than one reader spotted that we slipped up in the third item of these Short Cuts by Alison Tonks (BMJ 2006;332:1025-6, 29 Apr). Candesartan is an angiotensin II receptor antagonist, not an angiotensin converting enzyme inhibitor as we stated.

Footnotes

View Abstract